Cassone, Giulia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.576
AS - Asia 6.005
EU - Europa 4.568
SA - Sud America 927
Continente sconosciuto - Info sul continente non disponibili 245
AF - Africa 165
OC - Oceania 88
Totale 22.574
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.236
SG - Singapore 1.824
CN - Cina 1.502
IT - Italia 1.355
GB - Regno Unito 955
HK - Hong Kong 655
BR - Brasile 652
VN - Vietnam 607
SE - Svezia 467
DE - Germania 318
FI - Finlandia 309
BD - Bangladesh 269
FR - Francia 251
RU - Federazione Russa 222
KR - Corea 199
CA - Canada 171
JP - Giappone 160
TR - Turchia 159
IN - India 153
ID - Indonesia 147
UA - Ucraina 120
IE - Irlanda 109
AR - Argentina 97
MX - Messico 96
NL - Olanda 81
AU - Australia 78
BG - Bulgaria 72
PK - Pakistan 56
IQ - Iraq 53
TN - Tunisia 51
PL - Polonia 49
LT - Lituania 45
ZA - Sudafrica 40
EC - Ecuador 36
MY - Malesia 36
CL - Cile 34
CO - Colombia 34
ES - Italia 34
AT - Austria 27
PE - Perù 25
PT - Portogallo 24
VE - Venezuela 23
PH - Filippine 21
AE - Emirati Arabi Uniti 20
HU - Ungheria 20
SA - Arabia Saudita 20
JO - Giordania 17
DK - Danimarca 15
EG - Egitto 15
NP - Nepal 15
BE - Belgio 14
BZ - Belize 14
KE - Kenya 14
MA - Marocco 14
DZ - Algeria 12
IR - Iran 12
RS - Serbia 11
CH - Svizzera 10
NZ - Nuova Zelanda 10
RO - Romania 10
PY - Paraguay 9
TH - Thailandia 9
TW - Taiwan 9
UZ - Uzbekistan 9
BO - Bolivia 8
CR - Costa Rica 8
DO - Repubblica Dominicana 8
HN - Honduras 8
JM - Giamaica 8
LB - Libano 7
LV - Lettonia 7
CZ - Repubblica Ceca 6
NI - Nicaragua 6
OM - Oman 6
UY - Uruguay 6
AZ - Azerbaigian 5
BY - Bielorussia 5
CY - Cipro 5
GR - Grecia 5
GT - Guatemala 5
HR - Croazia 5
IL - Israele 5
TT - Trinidad e Tobago 5
EU - Europa 4
LU - Lussemburgo 4
MD - Moldavia 4
MU - Mauritius 4
EE - Estonia 3
GY - Guiana 3
KG - Kirghizistan 3
KH - Cambogia 3
KW - Kuwait 3
KZ - Kazakistan 3
PA - Panama 3
PS - Palestinian Territory 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
Totale 22.301
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.308
Singapore 1.159
Ashburn 1.078
Fairfield 853
Hong Kong 632
San Jose 594
Chandler 507
Hefei 464
Southend 451
Council Bluffs 404
Woodbridge 342
Houston 293
Seattle 279
Nyköping 264
Wilmington 264
London 263
Helsinki 261
Cambridge 241
Beijing 233
Los Angeles 217
Ann Arbor 215
The Dalles 214
New York 187
Ho Chi Minh City 182
Seoul 169
Jacksonville 143
Hanoi 136
Milan 135
Dallas 127
Modena 123
Chicago 112
Dearborn 110
Jakarta 105
San Diego 97
Shanghai 89
Moscow 79
Buffalo 78
Dublin 76
Rome 76
Lauterbourg 71
Sofia 70
Princeton 68
São Paulo 65
Redwood City 64
Tokyo 60
Orem 59
Munich 56
Columbus 53
Bologna 50
Salt Lake City 48
Perth 47
Frankfurt am Main 42
Izmir 41
Bremen 39
Montreal 39
Boardman 38
Eugene 36
Da Nang 35
Mexico City 35
Manchester 33
Toronto 33
Elk Grove Village 29
Nuremberg 29
San Francisco 29
Kent 27
Warsaw 27
Atlanta 26
Boston 26
Chennai 26
Mumbai 26
Brooklyn 25
Falls Church 25
Haiphong 25
Istanbul 25
Bari 24
Ankara 22
Phoenix 22
Baghdad 21
Redondo Beach 21
Rio de Janeiro 21
Santiago 21
Amsterdam 20
Naples 20
Paris 19
Turku 19
Dong Ket 18
Johannesburg 18
Guangzhou 17
Catania 16
Denver 16
Las Vegas 16
North Bergen 16
Ottawa 16
Quito 16
Stockholm 16
Bogotá 15
Brasília 15
Buenos Aires 15
Turin 15
Amman 14
Totale 14.456
Salva come PNG Salva come JPEG
Nome #
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.380
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 421
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 413
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 357
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 357
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 354
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 349
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 332
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 330
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 328
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 327
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 325
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 318
Caratteristiche cliniche e nuovi orizzonti diagnostico-terapeutici delle vasculiti dei grandi vasi e della interstiziopatia polmonare secondaria ad artrite reumatoide. 312
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 312
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 306
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 306
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 304
High-dose glucocorticoids pulse-Therapy for beta-coronaviridae pneumonia: A systematic literature review and case-series of coronavirus disease-2019 296
The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients 294
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 289
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 264
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 264
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 262
[18F]fluorodeoxyglucose positron emission tomography imaging in a case of relapsing polychondritis 261
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 257
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 254
Classification of pulmonary sounds through deep learning for the diagnosis of interstitial lung diseases secondary to connective tissue diseases 248
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 247
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 243
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 243
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry 243
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 234
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 234
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 233
Nailfold videocapillaroscopy in antisynthetase syndrome 233
Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature 232
Severe alopecia complicating systemic sclerosis 230
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 223
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 218
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium 217
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 211
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 210
Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases 208
VECTOR: An algorithm for the detection of COVID-19 pneumonia from velcro-like lung sounds 208
FRI0613 THERAPEUTIC STRATEGIES AND SURVIVAL IN PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES 205
Human Dental Pulp Stem Cells Modulate Cytokine Production in vitro by Peripheral Blood Mononuclear Cells From Coronavirus Disease 2019 Patients 205
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming? 203
Granulomatosis with polyangiitis presenting as a renal mass successfully treated with rituximab 201
Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis 201
Treatment with Rituximab in Systemic Sclerosis Patients: Our Experience in a Pilot Clinical Trial 194
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows 189
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 189
The rediscovery of hydroxychloroquine in allergic diseases in the covid-19 era 184
EVALUATION OF INTERNAL CONSISTENCY, FEASIBILITY, AND RELIABILITY OF THE ITALIAN VERSION OF ANCA-ASSOCIATED VASCULITIS PATIENT-REPORTED OUTCOME (AAV-PRO_ITA) QUESTIONNAIRE: PRELIMINARY RESULTS FROM A MULTICENTER STUDY ON A LARGE COHORT OF ITALIAN PATIENTS 183
Diagnosis, Clinical Features and Management of Interstitial Lung Diseases in Rheumatic Disorders: Still a Long Journey 183
EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 180
NAILFOLD CAPILLAROSCOPIC ALTERATIONS IN DERMATOMYOSITIS AND POLYMYOSITIS 180
Fibrosing interstitial lung disease in primary Sjogren syndrome 179
Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium” 176
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study 175
Rheumatoid arthritis related interstitial lung disease 175
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 175
Interstitial pneumonia with autoimmune features: Why rheumatologist–pulmonologist collaboration is essential 173
Lung involvement in systemic sclerosis: role of high resolution computed tomography and its relationship with other pulmonary and clinico-serological features. 168
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 166
117. PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG– STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 161
354. EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 161
Effects in soluble immune checkpoints induced by Tocilizumab monotherapy after ultra-short-term glucocorticoids in large vessel – giant cell arteritis patients 159
Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia 159
Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association 159
Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia: An observational study 158
CLINICAL OUTCOMES OF TREATMENT WITH GOLIMUMAB IN SEROPOSITIVE AND SERONEGATIVE RHEUMATOID ARTHRITIS PATIENTS IN REAL-LIFE SETTINGS. DATA FROM ITALIAN REGISTER GISEA 157
JANUS KINASES INHIBITORS IN CLINICAL PRACTICE IN ITALY. RESULTS FROM A SINGLE CENTER EXPERIENCE 157
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 149
Predictive factors of clinical outcomes in patients with COVID-19 treated with tocilizumab: A monocentric retrospective analysis 149
Pneumopathie interstitielle fibrosante dans le syndrome de Gougerot-Sjögren primitif 148
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology 147
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study 147
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study 144
Erratum to: Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement (Clinical Rheumatology, (2017), 36, 6, (1261-1268), 10.1007/s10067-017-3601-1) 142
Granuloma annulare as a possible new adverse effect of topiramate 141
SAT0470 Pap-Test Features in a Cohort of Systemic Sclerosis Patients 138
Reactive Granulomatous Dermatitis during Anti-TNF Therapy: A Case Report and Review of the Literature 136
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 135
Trattamento con Tocilizumab in monoterapia dopo trattamento con glucocorticoidi per breve periodo in pazienti con arterite a cellule giganti con coinvolgimento dei grandi vasi: effetti sui checkpoint immunitari solubili 135
Therapeutic Strategies and Survival in Patients with Interstitial Pneumonia with Autoimmune Features 132
FRI0212 THE ROLE OF AGE ON THE CLINICAL PRESENTATION AND RELAPSE RATES IN A LARGE COHORT OF 720 PATIENTS WITH GIANT CELL ARTERITIS 131
Prevalence of Progressive Fibrosing Interstitial Lung Disease in Patients with Primary Sjogren Syndrome 131
POS1053 PREVALENCE OF FIBROSING PROGRESSIVE INTERSTITIAL LUNG DISEASE IN RHEUMATOID ARTHRITIS PATIENTS 124
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 124
From Bench to Bedside in Rheumatoid Arthritis from the “2022 GISEA International Symposium” 113
NAILFOLD CAPILLAROSCOPY IN ANTISYNTHETASE SYNDROME (NASCAR): RESULTS OF A MULTICENTER, INTERNATIONAL STUDY OF THE AMERICAN AND EUROPEAN NETWORK OF ANTISYNTHETASE SYNDROME (AENEAS) 112
Rheumatoid arthritis extra-articular lung disease: new insights on pathogenesis and experimental drugs 108
EARLY DISCONTINUATION OF FIRST LINE BIOLOGICAL TREATMENT WITH ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE ITALIAN GISEA REGISTRY 105
Radiomics to predict the mortality of patients with rheumatoid arthritis-associated interstitial lung disease: A proof-of-concept study 105
Rheumatoid Arthritis from Easy to Complex Disease: From the "2022 GISEA International Symposium" 101
Efficacy and safety of mepolizumab in eosinophilic granulomatosis with polyangiitis: Insights from real-life cases and literature analysis 98
HARNESSING THE POWER OF RADIOMICS TO PREDICT SURVIVAL IN PATIENTS WITH RA-ILD 95
PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG-STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 94
Totale 22.126
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.352
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.352
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.603 0 106 111 99 91 137 81 91 209 173 321 184
2022/20231.874 211 178 145 138 211 215 87 207 230 47 115 90
2023/20241.590 68 89 75 232 219 125 129 254 47 54 123 175
2024/20254.678 143 69 108 319 961 737 396 205 489 174 451 626
2025/20268.095 533 368 640 920 975 599 1.041 390 882 682 584 481
2026/2027766 231 535 0 0 0 0 0 0 0 0 0 0
Totale 22.574